Brief: Tongfang Kontafarma Says Resumed Making Active Pharmaceutical Ingredients Chloroquine Phosphate
03/02/2020 15:11
Feb 3 (Reuters) - Tongfang Kontafarma Holdings Ltd
1312.HK :
* NOTIFIED THAT CHLOROQUINE PHOSPHATE TESTED & PROVED TO
HAVE SOME
CURATIVE EFFECT IN COMBATING CORONAVIRUS INFECTION
* UNIT REQUESTED BY MIIT'S DIVISION TO PRODUCING ACTIVE
PHARMACEUTICAL INGREDIENTS CHLOROQUINE PHOSPHATE
* CHONGQING KANGLE REQUESTED TO RESUME WORK EARLIER THAN FEB
10
* AS AT FEB 3, UNIT RESUMED MAKING ACTIVE PHARMACEUTICAL
INGREDIENTS CHLOROQUINE PHOSPHATE
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7LlpQm
Further company coverage: 1312.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Kontafarma China Holdings
See all newsBrief: Kontafarma China Holdings Announces Creditors' Voluntary Winding-Up Of Singapore Subsidiaries
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr